Wescap Management Group, Inc. Laboratory Corp Of America Holdings Transaction History

Wescap Management Group, Inc.

$395 Million
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$209.01 - $232.56 $9,196 - $10,232	-44 Reduced 2.09%	2,060 $450,000
Q4 2023 Feb 06, 2024	SELL	$197.69 - $227.29 $20,955 - $24,092	-106 Reduced 4.8%	2,104 $478,000
Q3 2023 Nov 13, 2023	SELL	$201.05 - $221.7 $20,105 - $22,170	-100 Reduced 4.33%	2,210 $444,000
Q1 2023 May 04, 2023	SELL	$213.32 - $257.83 $25,385 - $30,681	-119 Reduced 4.9%	2,310 $529,000
Q4 2022 Feb 10, 2023	SELL	$203.72 - $248.97 $27,502 - $33,610	-135 Reduced 5.27%	2,429 $571,000
Q3 2022 Nov 02, 2022	SELL	$204.81 - $262.19 $94,827 - $121,393	-463 Reduced 15.3%	2,564 $525,000
Q2 2022 Aug 11, 2022	SELL	$213.86 - $277.87 $1.02 Million - $1.33 Million	-4,789 Reduced 61.27%	3,027 $709,000
Q1 2022 May 11, 2022	SELL	$259.82 - $298.18 $53,263 - $61,126	-205 Reduced 2.56%	7,816 $2.06 Million
Q4 2021 Feb 11, 2022	SELL	$271.6 - $314.21 $52,147 - $60,328	-192 Reduced 2.34%	8,021 $2.52 Million
Q3 2021 Nov 12, 2021	SELL	$274.82 - $308.34 $132,463 - $148,619	-482 Reduced 5.54%	8,213 $2.31 Million
Q2 2021 Aug 02, 2021	SELL	$251.87 - $278.14 $243,810 - $269,239	-968 Reduced 10.02%	8,695 $2.4 Million
Q1 2021 May 07, 2021	SELL	$204.88 - $255.03 $51,015 - $63,502	-249 Reduced 2.51%	9,663 $2.46 Million
Q4 2020 Feb 10, 2021	SELL	$186.91 - $214.42 $114,202 - $131,010	-611 Reduced 5.81%	9,912 $2.02 Million
Q3 2020 Nov 12, 2020	SELL	$167.03 - $201.3 $59,295 - $71,461	-355 Reduced 3.26%	10,523 $1.98 Million
Q2 2020 Aug 06, 2020	SELL	$113.31 - $182.44 $22,435 - $36,123	-198 Reduced 1.79%	10,878 $1.81 Million
Q1 2020 May 13, 2020	BUY	$104.32 - $195.28 $11,683 - $21,871	112 Added 1.02%	11,076 $1.4 Million
Q4 2019 Feb 05, 2020	SELL	$163.48 - $173.61 $1,961 - $2,083	-12 Reduced 0.11%	10,964 $1.85 Million
Q3 2019 Nov 13, 2019	SELL	$159.77 - $178.1 $146,349 - $163,139	-916 Reduced 7.7%	10,976 $1.84 Million
Q2 2019 Aug 06, 2019	BUY	$144.16 - $172.9 $7,063 - $8,472	49 Added 0.41%	11,892 $2.06 Million
Q1 2019 May 06, 2019	SELL	$123.7 - $156.3 $44,408 - $56,111	-359 Reduced 2.94%	11,843 $1.81 Million
Q4 2018 Feb 11, 2019	SELL	$120.82 - $174.09 $17,881 - $25,765	-148 Reduced 1.2%	12,202 $1.54 Million
Q3 2018 Nov 07, 2018	SELL	$167.67 - $188.27 $72,601 - $81,520	-433 Reduced 3.39%	12,350 $2.14 Million
Q2 2018 Aug 07, 2018	BUY	$160.33 - $189.41 $42,487 - $50,193	265 Added 2.12%	12,783 $2.29 Million
Q1 2018 May 03, 2018	SELL	$161.53 - $178.11 $45,874 - $50,583	-284 Reduced 2.22%	12,518 $2.02 Million
Q4 2017 Feb 13, 2018	BUY	$147.99 - $163.95 $22,198 - $24,592	150 Added 1.19%	12,802 $2.04 Million
Q3 2017 Nov 08, 2017	BUY	$149.47 - $160.56 $1.89 Million - $2.03 Million	12,652	12,652 $1.91 Million

Others Institutions Holding LH

# of Institutions

Shares Held

1.94M

Call Options Held

Put Options Held

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wescap Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wescap Management Group, Inc. with notifications on news.

Account